Skip to main content
FinSpry Logo
FinSpry
CTMX logo
CTMX
(NASDAQ)
CytomX Therapeutics, Inc.
$3.15-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

CytomX Therapeutics (CTMX) Stock Price & Financial Analysis

CytomX Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.01 - $3.22
52-Week High$8.21
52-Week Low$1.72
Open$3.04
Volume3.55M
Average Volume (3M)3.85M
Market Cap558.41M
Shares Outstanding177.27M
Price to Sales (P/S)15.71
Price to Book (P/B)1.75
EV/EBITDA-8.60
Revenue (TTM)35.54M
Net Income (TTM)-59.14M
Free Cash Flow (TTM)-80.19M
EPS (TTM)$-0.37
Profit Margin-166.40%
Operating Margin-181.92%
Return on Equity (ROE)-18.48%
Debt to Equity0.01
50-Day MA$3.77
200-Day MA$4.07
52-Week Change45.83%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About CytomX Therapeutics

What is the current stock price for CTMX?

As of the latest trading session, CTMX stock trades at $3.15. The 52-week range is $1.72–$8.21, with a day range of $3.01–$3.22.

What is the P/E ratio for CTMX?

The P/E ratio (Price-to-Earnings) for CTMX is shown in the Key Statistics section. This valuation metric helps compare CytomX Therapeutics, Inc. to industry peers.

Does CTMX pay dividends?

CytomX Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CTMX?

Based on 6 analysts, the consensus for CTMX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CTMX?

CytomX Therapeutics's market capitalization is $558.4M, classifying it as a small-cap company. CytomX Therapeutics operates in the Healthcare sector within the Biotechnology industry.